N4 Pharma PLC (N4P) — Cash Flow Reinvestment Rate
Latest as of December 2011:
1.32x
N4 Pharma PLC (N4P) has a Cash Flow Reinvestment Rate of 1.32x as of December 2011, reinvesting GBX655.00K (capex GBX655.00K ) from operating cash flow of GBX496.50K. See N4 Pharma PLC (N4P) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
1.32x
(Capex + Investments) / Operating CF
Total Reinvested
GBX655.00K
Capex + Investments
Operating Cash Flow
GBX496.50K
GBX
Capital Expenditures
GBX655.00K
GBX
N4 Pharma PLC Cash Flow Reinvestment Rate (1992–2011)
Historical reinvestment intensity for N4 Pharma PLC across 12 annual periods. For the full cash flow conversion analysis, see N4P cash flow metrics.
Annual Cash Flow Reinvestment Rate for N4 Pharma PLC (1992–2011)
Year-by-year capital reinvestment analysis for N4 Pharma PLC. See N4P financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (GBX) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2011 | 1.32x | GBX1.31 Million | GBX996.00K | GBX1.31 Million | ▼ -30.2% |
| 2010 | 1.88x | GBX469.00K | GBX249.00K | GBX469.00K | ▲ +53.2% |
| 2009 | 1.23x | GBX928.00K | GBX755.00K | GBX928.00K | ▲ +2085.1% |
| 2007 | 0.06x | GBX9.00K | GBX160.00K | GBX9.00K | ▼ -87.5% |
| 2004 | 0.45x | GBX63.00K | GBX140.00K | GBX63.00K | ▼ -70.8% |
| 2003 | 1.54x | GBX131.00K | GBX85.00K | GBX131.00K | ▲ +1698.0% |
| 2001 | 0.09x | GBX18.00K | GBX210.00K | GBX18.00K | ▼ -95.3% |
| 1996 | 1.82x | GBX3.67 Million | GBX2.02 Million | GBX3.67 Million | ▼ -92.4% |
| 1995 | 24.09x | GBX3.93 Million | GBX163.00K | GBX3.93 Million | ▲ +2837.9% |
| 1994 | 0.82x | GBX2.73 Million | GBX3.34 Million | GBX2.73 Million | ▼ -69.2% |
| 1993 | 2.66x | GBX824.00K | GBX310.00K | GBX824.00K | ▲ +1046.6% |
| 1992 | 0.23x | GBX631.00K | GBX2.72 Million | GBX631.00K | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow